Roche's experimental drug fenebrutinib achieved significant results in a Phase III trial for primary progressive multiple sclerosis (PPMS), reducing the risk of disability progression by 12%. This ...
WEHT Evansville on MSN
KDE honors Hopkins County for excellence in alternative education
HENDERSON, Ky. (WEHT) – The Kentucky Department of Education (KDE) has announced the selection of several alternative ...
We’re very grateful that you’re out here today to enable us to fill out that picture and understand exactly what these cuts ...
First publication of clinical efficacy data for PP353, in development for chronic Low Back PainTrial demonstrated that PP353 ...
Children with mild autism will not need a diagnosis to access the Thriving Kids scheme when Labor’s alternative to the NDIS ...
There's a looming crisis for Arizonans on the autism spectrum, as the cost of a popular form of therapy spirals out of ...
A Cannock based charity which has stores selling brand new stock around the UK, has been shortlisted as a finalist for a ...
The top court cites lack of scientific evidence, ethical violations, and regulatory failures that have pushed desperate ...
Persistent dysfunctions endure across countries despite reforms — the problem is paradigmatic, not operational.
News-Medical.Net on MSN
Transcranial magnetic stimulation can be a cost-effective treatment option for depression
A major new study has found that transcranial magnetic stimulation (TMS), which applies magnetic energy to the brain, can be ...
The federal government has released the model for its Thriving Kids program, aimed at setting up services and supports run by states and territories outside the NDIS.
News-Medical.Net on MSN
Large trials show statins rarely cause reported side effects
Cardiovascular disease results in around 20 million deaths worldwide and causes around a quarter of all deaths in the UK.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results